Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Abbvie Inc (ABBV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 170,003,840
  • Shares Outstanding, K 1,596,430
  • Annual Sales, $ 25,638 M
  • Annual Income, $ 5,953 M
  • 36-Month Beta 1.52
  • Price/Sales 6.28
  • Price/Cash Flow 18.70
  • Price/Book 24.94

Price Performance

See More
Period Period Low Period High Performance
1-Month
96.71 +10.10%
on 12/29/17
106.97 -0.46%
on 01/23/18
+8.27 (+8.42%)
since 12/22/17
3-Month
85.24 +24.92%
on 10/26/17
106.97 -0.46%
on 01/23/18
+11.97 (+12.67%)
since 10/23/17
52-Week
59.27 +79.65%
on 01/30/17
106.97 -0.46%
on 01/23/18
+45.52 (+74.67%)
since 01/23/17

Most Recent Stories

More News
J&J (JNJ) Q4 Earnings Top, Pharma Sales Continue to Improve

J&J (JNJ) beat estimates for earnings while missing the same for sales in the fourth-quarter. It issued a mixed outlook for 2018.

JNJ : 144.48 (-2.47%)
MRK : 61.88 (+1.03%)
ABBV : 106.67 (+0.17%)
GSK : 38.87 (+0.80%)
The Zacks Analyst Blog Highlights: Alexion Pharmaceuticals, Celgene, AbbVie and Merck

The Zacks Analyst Blog Highlights: Alexion Pharmaceuticals, Celgene, AbbVie and Merck

CELG : 105.08 (+2.11%)
MRK : 61.88 (+1.03%)
ABBV : 106.67 (+0.17%)
ALXN : 125.01 (+1.08%)
Healthcare ETFs to Watch As Q4 Earnings Unfold

With earnings surprises well in the cards, the healthcare sector is expected to witness earnings growth of 3% in the fourth quarter, suggesting some upside for healthcare ETFs.

XLV : 89.02 (-0.15%)
VHT : 166.14 (-0.02%)
JNJ : 144.48 (-2.47%)
MRK : 61.88 (+1.03%)
IYH : 187.41 (-0.05%)
FHLC : 43.13 (+0.05%)
ABBV : 106.67 (+0.17%)
GILD : 81.36 (-0.06%)
AMGN : 194.08 (+0.91%)
PFE : 36.90 (-0.08%)
BMY : 63.19 (-0.14%)
What's in the Cards for Varian Medical (VAR) in Q1 Earnings?

Varian Medical's (VAR) lackluster performance in Halcyon platform and disappointing financials are likely to dampen results in Q1.

AGIO : 78.90 (+0.70%)
VAR : 110.30 (+0.25%)
ABBV : 106.67 (+0.17%)
ALXN : 125.01 (+1.08%)
What's in the Cards for Novartis (NVS) This Earnings Season?

Novartis has an excellent track record. We expect investors to focus on the performance of new drugs and revival of Alcon business.

VRTX : 164.40 (+1.54%)
NVS : 87.70 (+0.80%)
ABBV : 106.67 (+0.17%)
AMGN : 194.08 (+0.91%)
Will These 4 Large-Cap Drug Stocks Be Big Winners This Earnings Season?

Here is a look at four large-cap pharma and biotech stocks including Merck (MRK) that could surpass earnings expectations in the fourth quarter.

CELG : 105.08 (+2.11%)
MRK : 61.88 (+1.03%)
ABBV : 106.67 (+0.17%)
JUNO : 85.96 (-0.05%)
SNY : 43.79 (+1.37%)
ALXN : 125.01 (+1.08%)
BIIB : 352.83 (+1.49%)
Healthcare ETFs to Watch As Q4 Earnings Unfold

With earnings surprises well in the cards, the healthcare sector is expected to witness earnings growth of 3% in the fourth quarter, suggesting some upside for healthcare ETFs.

XLV : 89.02 (-0.15%)
VHT : 166.14 (-0.02%)
JNJ : 144.48 (-2.47%)
MRK : 61.88 (+1.03%)
IYH : 187.41 (-0.05%)
FHLC : 43.13 (+0.05%)
ABBV : 106.67 (+0.17%)
GILD : 81.36 (-0.06%)
AMGN : 194.08 (+0.91%)
PFE : 36.90 (-0.08%)
BMY : 63.19 (-0.14%)
Amgen/Allergan's Avastin Biosimilar Secures EU Approval

Amgen (AMGN) and Allergan's Mvasi - a biosimilar version of Roche's cancer drug, Avastin - gets marketing approval in the EU.

AGN : 186.43 (-0.91%)
ABBV : 106.67 (+0.17%)
RHHBY : 30.9300 (+0.45%)
AMGN : 194.08 (+0.91%)
The Zacks Analyst Blog Highlights: Johnson & Johnson, AbbVie, Amgen, Novo-Nordisk and Zoetis

The Zacks Analyst Blog Highlights: Johnson & Johnson, AbbVie, Amgen, Novo-Nordisk and Zoetis

NVO : 58.08 (+0.22%)
JNJ : 144.48 (-2.47%)
ZTS : 77.51 (+0.04%)
ABBV : 106.67 (+0.17%)
AMGN : 194.08 (+0.91%)
The Zacks Analyst Blog Highlights: Apple, JPMorgan, AbbVie, Gilead and Simon Property Group

The Zacks Analyst Blog Highlights: Apple, JPMorgan, AbbVie, Gilead and Simon Property Group

AAPL : 178.10 (+0.62%)
JPM : 113.99 (-0.30%)
ABBV : 106.67 (+0.17%)
GILD : 81.36 (-0.06%)
SPG : 168.43 (+1.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation...

See More

Key Turning Points

2nd Resistance Point 107.91
1st Resistance Point 107.20
Last Price 106.67
1st Support Level 105.12
2nd Support Level 103.75

See More

52-Week High 106.97
Last Price 106.67
Fibonacci 61.8% 88.75
Fibonacci 50% 83.12
Fibonacci 38.2% 77.49
52-Week Low 59.27

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.